Literature DB >> 11954664

Central administration of neuromedin U activates neurons in ventrobasal hypothalamus and brainstem.

M Niimi1, K Murao, T Taminato.   

Abstract

Neuromedin U (NMU) is a peptide isolated from the porcine spinal cord. Recently, two receptors for NMU have been identified and characterized. A recent study indicated that NMU is an anorectic chemical in the brain. The present study shows that NMU has an action in the brain to inhibit food intake in rats. Intracerebroventricular injection of NMU inhibited dark-phase feeding. Animals injected with NMU showed a strong increase in Fos-immunoreactive nuclei in the paraventricular nucleus (PVN) and supraoptic nucleus (SON) of the hypothalamus, and in the parabrachial nucleus of the brain stem. Double immunohistochemistry revealed that a high number of oxytocin-immunoreactive neurons in the PVN and SON contained Fos after intracerebroventricular injection of NMU. In addition, a small proportion of vasopressinergic cells within the PVN and SON were found to contain Fos. The effect of NMU on the hypothalamus and brain stem contributes to the inhibitory effects of NMU on feeding behavior.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11954664     DOI: 10.1385/ENDO:16:3:201

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  19 in total

1.  Purification and identification of neuromedin U as an endogenous ligand for an orphan receptor GPR66 (FM3).

Authors:  M Kojima; R Haruno; M Nakazato; Y Date; N Murakami; R Hanada; H Matsuo; K Kangawa
Journal:  Biochem Biophys Res Commun       Date:  2000-09-24       Impact factor: 3.575

2.  Organization of cortical, basal forebrain, and hypothalamic afferents to the parabrachial nucleus in the rat.

Authors:  M M Moga; H Herbert; K M Hurley; Y Yasui; T S Gray; C B Saper
Journal:  J Comp Neurol       Date:  1990-05-22       Impact factor: 3.215

3.  Oxytocin and an oxytocin agonist administered centrally decrease food intake in rats.

Authors:  B R Olson; M D Drutarosky; M S Chow; V J Hruby; E M Stricker; J G Verbalis
Journal:  Peptides       Date:  1991 Jan-Feb       Impact factor: 3.750

4.  Localization of 7B2, neuromedin B, and neuromedin U in specific cell types of rat, mouse, and human pituitary, in rat hypothalamus, and in 30 human pituitary and extrapituitary tumors.

Authors:  J H Steel; S Van Noorden; J Ballesta; S J Gibson; M A Ghatei; J Burrin; U Leonhardt; J Domin; S R Bloom; J M Polak
Journal:  Endocrinology       Date:  1988-01       Impact factor: 4.736

Review 5.  Stimulus-transcription coupling in neurons: role of cellular immediate-early genes.

Authors:  J I Morgan; T Curran
Journal:  Trends Neurosci       Date:  1989-11       Impact factor: 13.837

6.  Effects of central and peripheral injection of leptin on food intake and on brain Fos expression in the Otsuka Long-Evans Tokushima Fatty rat with hyperleptinaemia.

Authors:  M Niimi; M Sato; R Yokote; S Tada; J Takahara
Journal:  J Neuroendocrinol       Date:  1999-08       Impact factor: 3.627

7.  Identification of receptors for neuromedin U and its role in feeding.

Authors:  A D Howard; R Wang; S S Pong; T N Mellin; A Strack; X M Guan; Z Zeng; D L Williams; S D Feighner; C N Nunes; B Murphy; J N Stair; H Yu; Q Jiang; M K Clements; C P Tan; K K McKee; D L Hreniuk; T P McDonald; K R Lynch; J F Evans; C P Austin; C T Caskey; L H Van der Ploeg; Q Liu
Journal:  Nature       Date:  2000-07-06       Impact factor: 49.962

8.  Immunohistochemical identification of neurons in the paraventricular nucleus of the hypothalamus that project to the medulla or to the spinal cord in the rat.

Authors:  P E Sawchenko; L W Swanson
Journal:  J Comp Neurol       Date:  1982-03-01       Impact factor: 3.215

9.  Primary structure of neuromedin U from the rat.

Authors:  J M Conlon; J Domin; L Thim; V DiMarzo; H R Morris; S R Bloom
Journal:  J Neurochem       Date:  1988-09       Impact factor: 5.372

10.  Characterization of complementary DNA encoding the rat neuromedin U precursor.

Authors:  G Lo; S Legon; C Austin; S Wallis; Z Wang; S R Bloom
Journal:  Mol Endocrinol       Date:  1992-10
View more
  15 in total

1.  Effects of peripheral administration of a Neuromedin U receptor 2-selective agonist on food intake and body weight in obese mice.

Authors:  T Kaisho; H Nagai; T Asakawa; N Suzuki; H Fujita; K Matsumiya; N Nishizawa; Y Kanematsu-Yamaki; K Dote; J-I Sakamoto; T Asami; S Takekawa
Journal:  Int J Obes (Lond)       Date:  2017-07-31       Impact factor: 5.095

Review 2.  Neuropeptides controlling energy balance: orexins and neuromedins.

Authors:  Joshua P Nixon; Catherine M Kotz; Colleen M Novak; Charles J Billington; Jennifer A Teske
Journal:  Handb Exp Pharmacol       Date:  2012

3.  Neuromedin U receptor 2-deficient mice display differential responses in sensory perception, stress, and feeding.

Authors:  Hongkui Zeng; Alexander Gragerov; John G Hohmann; Maria N Pavlova; Brian A Schimpf; Hui Xu; Long-Jun Wu; Hiroki Toyoda; Ming-Gao Zhao; Alex D Rohde; Galina Gragerova; Rene Onrust; John E Bergmann; Min Zhuo; George A Gaitanaris
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

Review 4.  Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S.

Authors:  J D Mitchell; J J Maguire; A P Davenport
Journal:  Br J Pharmacol       Date:  2009-06-10       Impact factor: 8.739

5.  Sensitivity of the hypothalamic paraventricular nucleus to the locomotor-activating effects of neuromedin U in obesity.

Authors:  Colleen M Novak; Minzhi Zhang; James A Levine
Journal:  Brain Res       Date:  2007-07-13       Impact factor: 3.252

6.  Differential effects of selective agonists of neuromedin U1 and U2 receptors in obese and diabetic mice.

Authors:  Hiroaki Nagai; Tomoko Kaisho; Kotaro Yokoyama; Tomoko Asakawa; Hisashi Fujita; Kouta Matsumiya; Jiro Noguchi; Kazue Tsuchimori; Naoki Nishizawa; Yoko Kanematsu-Yamaki; Katsuko Dote; Hiroshi Inooka; Jun-Ichi Sakamoto; Tetsuya Ohtaki; Taiji Asami; Shiro Takekawa
Journal:  Br J Pharmacol       Date:  2017-12-18       Impact factor: 8.739

7.  Appetite-modifying actions of pro-neuromedin U-derived peptides.

Authors:  David A Bechtold; Tina R Ivanov; Simon M Luckman
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-06-16       Impact factor: 4.310

8.  Neuromedins U and S involvement in the regulation of the hypothalamo-pituitary-adrenal axis.

Authors:  Ludwik K Malendowicz; Agnieszka Ziolkowska; Marcin Rucinski
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-05       Impact factor: 5.555

9.  Negative regulation of neuromedin U mRNA expression in the rat pars tuberalis by melatonin.

Authors:  Sayaka Aizawa; Ichiro Sakata; Mai Nagasaka; Yuriko Higaki; Takafumi Sakai
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

10.  The Anorexigenic Peptide Neuromedin U (NMU) Attenuates Amphetamine-Induced Locomotor Stimulation, Accumbal Dopamine Release and Expression of Conditioned Place Preference in Mice.

Authors:  Daniel Vallöf; Jesper Vestlund; Jörgen A Engel; Elisabet Jerlhag
Journal:  PLoS One       Date:  2016-05-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.